Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Immunic presses ahead with MS drug despite Phase II endpoint miss
Clinical Trials Arena
Thursday, May 1, 2025 - 10:15pm
tags:
Immunic, MS, vidofludimus calcium, clinical trials, multiple sclerosis
Madrigal’s MASH drug sales again top Wall Street projections
BioPharma Dive
Thursday, May 1, 2025 - 10:13pm
tags:
Madrigal Pharmaceuticals, Rezdiffra, earnings, MASH
CVS to boost access to Novo Nordisk’s weight loss treatment Wegovy for patients on its drug plans
CNBC
Thursday, May 1, 2025 - 11:10am
tags:
Novo Nordisk, CVS Health, Wegovy, obesity, Caremark, PBMs
Abbott integrates diabetes data into Epic’s electronic health records
Medtech Dive
Thursday, May 1, 2025 - 11:09am
tags:
Abbott Labs, Medtech, FreeStyle Libre, CGMs, EHRs, diabetes
Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance
Yahoo Finance
Thursday, May 1, 2025 - 11:00am
tags:
Eli Lilly, earnings
GE Healthcare slashes 2025 profit forecast on tariff impact
Medtech Dive
Thursday, May 1, 2025 - 10:58am
tags:
Medtech, earnings, GE Healthcare, tariffs
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
CNBC
Thursday, May 1, 2025 - 10:58am
tags:
Pfizer, Pharma CEOs, Albert Bourla, drug manufacturing, tariffs
Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay
Fierce Biotech
Thursday, May 1, 2025 - 10:57am
tags:
Moderna Therapeutics, vaccines, earnings, FDA, mRNA-1083
AstraZeneca's China woes recede as focus shifts to upcoming readouts
First Word Pharma
Thursday, May 1, 2025 - 10:54am
tags:
AstraZeneca, China
Biogen earnings beat by $0.06, revenue topped estimates
Investing.com
Thursday, May 1, 2025 - 9:54am
tags:
Biogen, earnings
CVS Plans To Exit Obamacare In 2026, Impacting 1 Million Aetna Members
Forbes
Thursday, May 1, 2025 - 9:50am
tags:
CVS Health, insurance, Aetna, ACA
Biopharma VC financing fell 20% in Q1 compared to ’24: GlobalData
Fierce Biotech
Thursday, May 1, 2025 - 9:49am
tags:
funding, venture capital, biotech
US is planning $500m project on 'universal vaccines'
Pharmaphorum
Thursday, May 1, 2025 - 9:48am
tags:
federal government, vaccines, R&D, universal vaccines
Amylyx doses first subject in trial of post-bariatric hypoglycemia treatment
Clinical Trials Arena
Thursday, May 1, 2025 - 9:47am
tags:
Amylyx, clinical trials, avexitide, post-bariatric hypoglycemia
Sanofi nets €10B from Opella stake sale, eyes more 'bolt-on' deals
Fierce Pharma
Wednesday, April 30, 2025 - 11:47pm
tags:
Sanofi, consumer health, Opella, M&A
Imfinzi approval positions AstraZeneca at forefront of perioperative MIBC
Clinical Trials Arena
Wednesday, April 30, 2025 - 11:45pm
tags:
AstraZeneca, Imfinzi, muscle-invasive bladder cancer, FDA
GSK’s Zejula reduces risk of progression and death in mesothelioma study
Clinical Trials Arena
Wednesday, April 30, 2025 - 11:41pm
tags:
GSK, Zejula, mesothelioma, clinical trials
J&J secures FDA OK for immune drug touted as future blockbuster
BioPharma Dive
Wednesday, April 30, 2025 - 11:39pm
tags:
JNJ, FDA, Imaavy, nipocalimab, myasthenia gravis
Novartis pays $800M upfront to buy Regulus for phase 3-ready kidney drug
Fierce Biotech
Wednesday, April 30, 2025 - 11:37pm
tags:
Novartis, Regulus, M&A, kidney disease
AstraZeneca’s Truqap fails in another Phase III trial
Clinical Trials Arena
Wednesday, April 30, 2025 - 11:25am
tags:
AstraZeneca, Truqap, clinical trials, prostate cancer, metastatic castration-resistant prostate cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.